Brazil to resume trial of China’s Sinovac coronavirus vaccine
Brazil‘s health regulator Anvisa has allowed the resumption of late-stage clinical trials for China’s Sinovac COVID-19 vaccine, which had been suspended due to the death of a volunteer that was … Read More